HC
Publicaties op Oncologisch.com
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as eerstelijns treatment for gevorderd squamous n...
Durvalumab Combined With Chemotherapy and SABR Therapy in Patiënten met Oligogemetastaseerd Non-small Cell Longkanker: A Multicenter Fase 2-Studie
Ivonescimab plus chemotherapie bij EGFR-variant NSCLC: fase II